On Monday, June 18th, BIO 2012 was much more subdued than I’d remembered seeing it in the past. However, it was just the first official day, and a number of breakout sessions touched on important topics.
Perhaps the most important of these topics is drug shortages. A panel of professionals from regulatory, manufacturing and patient welfare backgrounds discussed the topic. Kevin Whalen of Pfizer’s worldwide policy group, chaired the session, with:
Lou Di Genero, EVP and CSO for Leukemia and Lymophoma Society
Gerry Migliaccio, SVP Pfizer Global Supply Chain
From 'On Pharma'